Bellevue Group Ag Essa Pharma Inc. Transaction History
Bellevue Group Ag
- $5.93 Billion
- Q3 2024
A detailed history of Bellevue Group Ag transactions in Essa Pharma Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 7,879,583 shares of EPIX stock, worth $12.8 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
7,879,583
Previous 7,889,583
0.13%
Holding current value
$12.8 Million
Previous $41.5 Million
15.06%
% of portfolio
0.8%
Previous 0.69%
Shares
8 transactions
Others Institutions Holding EPIX
# of Institutions
35Shares Held
35.1MCall Options Held
15.8KPut Options Held
21K-
Bvf Inc San Francisco, CA8.75MShares$14.3 Million1.69% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.29MShares$6.99 Million2.21% of portfolio
-
Morgan Stanley New York, NY4.18MShares$6.82 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.32 Million0.32% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.74MShares$4.47 Million0.97% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $71.8M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...